Houston TX 甲状腺癌临床试验
12项针对 甲状腺癌的研究正在 Houston及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
Global Real World Data in Patients With Advanced Thyroid Cancer on Standard of Care and Specialized Interventions- Registry of Oncologic Outcomes With Testing and Treatment.
招募中观察性研究
- MD Anderson Cancer Center, Houston
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
招募中1/2 期
- MD Anderson Cancer Center, Houston
Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma
招募中
- The University of Texas M. D. Anderson Cancer Center, Houston
Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
招募中2 期
- MD Anderson Cancer Center, Houston
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- UT MD Anderson Cancer Center, Houston
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
招募中2 期
- MD Anderson Cancer Center, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
招募中1/2 期
- MD Anderson Cancer Center, Houston
An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy
招募中1 期欢迎健康志愿者
- M D Anderson Cancer Center, Houston
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
招募中1/2 期
- MD Anderson Cancer Center, Houston
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
招募中
- M D Anderson Cancer Center, Houston
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
招募中2 期
- MD Anderson Cancer Center, Houston
Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
招募中2 期
- MD Anderson Cancer Center, Houston
其他城市的 甲状腺癌试验
- Washington, DC10 项研究
- New York City, NY9 项研究
- Philadelphia, PA6 项研究
- Boston, MA6 项研究
- Durham, NC5 项研究
- Nashville, TN5 项研究
- Los Angeles, CA5 项研究
- San Francisco, CA4 项研究
- Ann Arbor, MI4 项研究
- Minneapolis, MN4 项研究
- Memphis, TN4 项研究
- San Antonio, TX4 项研究
Houston的其他研究
- 非小细胞肺癌145 项研究
- 乳腺癌126 项研究
- 癌症（所有类型）122 项研究
- 转移性癌症104 项研究
- 结直肠癌103 项研究
- 卵巢癌90 项研究
- 急性髓系白血病86 项研究
- 肺癌78 项研究
- 前列腺癌76 项研究
- 子宫内膜癌69 项研究
- 胰腺癌62 项研究
- 黑色素瘤59 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月1日。每项研究自行设定入选标准，由研究团队决定谁能参与。